P28.03 Durvalumab Adjuvant to Chemoradiation for Patients With Locally Advanced Non-Small Cell Lung Cancer: Real World Experience von Haakensen, V.D., Nymoen, H.M., Langberg, C.W., Horndalsveen, H., Farooqi, S., Bjaanæs, M., Helland, Å.

Volltext

P17.02 Durvalumab After chemoRadioTherapy (DART) for NSCLC Patients – a Phase II Translational and Biomarker Study von Haakensen, V.D., Horndalsveen, H., Nymoen, H.M., Holgersson, G., Land, L. Holm, Koivunen, J., Cicenas, S., Oselin, K., Madebo, T., Van Helvoirt, R., Helbekkmo, N., Grønberg, B.H., Aanerud, M., Rogg, L., Helland, Å.

Volltext